Cedar Mountain Advisors
PFE icon

Cedar Mountain Advisors’s Pfizer PFE Stock Holding History

Cedar Mountain Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.6K Buy
1,703
+12
+0.7% +$319 0.01% 160
2026
Q2 		$40.7K Buy
1,691
+60
+4% +$1.57K 0.01% 208
2026
Q1 		$45.8K Buy
1,631
+682
+72% +$18.2K 0.01% 164
2025
Q4 		$23.6K Buy
949
+12
+1% +$303 ﹤0.01% 169
2025
Q3 		$23.9K Buy
937
+26
+3% +$642 ﹤0.01% 171
2025
Q2 		$22.1K Buy
911
+12
+1% +$280 ﹤0.01% 154
2025
Q1 		$22.8K Buy
899
+12
+1% +$314 0.01% 145
2024
Q4 		$23.5K Buy
887
+24
+3% +$651 0.01% 144
2024
Q3 		$25K Buy
863
+10
+1% +$292 0.01% 136
2024
Q2 		$23.9K Buy
853
+11
+1% +$303 0.01% 125
2024
Q1 		$23.4K Buy
842
+11
+1% +$305 0.01% 126
2023
Q4 		$23.9K Buy
831
+9
+1% +$272 0.01% 118
2023
Q3 		$27.3K Buy
822
+8
+1% +$283 0.01% 95
2023
Q2 		$29.9K Buy
814
+7
+0.9% +$272 0.01% 98
2023
Q1 		$32.9K Buy
807
+6
+0.7% +$259 0.01% 91
2022
Q4 		$41K Buy
801
+5
+0.6% +$240 0.01% 82
2022
Q3 		$35K Buy
796
+6
+0.8% +$292 0.01% 83
2022
Q2 		$41K Buy
790
+5
+0.6% +$255 0.01% 81
2022
Q1 		$41K Buy
785
+5
+0.6% +$259 0.01% 88
2021
Q4 		$46K Buy
780
+5
+0.6% +$248 0.01% 77
2021
Q3 		$33K Sell
775
-67
-8% -$2.97K 0.01% 91
2021
Q2 		$33K Hold
842
– – 0.01% 93
2021
Q1 		$31K Hold
842
– – 0.01% 97
2020
Q4 		$31K Buy
842
+271
+47% +$9.9K 0.01% 99
2020
Q3 		$20K Hold
571
– – 0.01% 106
2020
Q2 		$18K Hold
571
– – 0.01% 110
2020
Q1 		$18K Hold
571
– – 0.01% 93
2019
Q4 		$21K Buy
+571
New +$20.3K 0.01% 106

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Cedar Mountain Advisors's PFE Position: Q3 2026 in Review

Cedar Mountain Advisors increased its Pfizer (PFE) stake by 0.71% in Q3 2026, buying an estimated $319 and bringing the position to 1,703 shares worth $48.6K. The position accounts for 0.01% of the portfolio, ranked #160.

Cedar Mountain Advisors first reported a position in PFE in Q4 2019 and has held it in 28 quarters since. 656 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Cedar Mountain Advisors held 1,703 shares of Pfizer worth $48.6K as of Q3 2026.
  • Cedar Mountain Advisors bought 12 Pfizer shares in Q3 2026, an estimated $319.
  • Pfizer made up 0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #160 holding.
  • Cedar Mountain Advisors first reported a position in Pfizer in Q4 2019 and has held it in 28 quarters since.
  • 656 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.